Table 1 Demographic and baseline characteristics of patients included in the study. Data are expressed as mean ± standard deviation (SD) or as number of patients (percentage). TIR time in range. MDI multiple daily injections
From: The effect of COVID-19 lockdown on the glycemic control of children with type 1 diabetes
Parameter | Value |
|---|---|
Number of patients | 245 |
Male (n, %) | 130 (53%) |
Female (n, %) | 115 (47%) |
Age (years, mean ± SD) | 11.06 ± 2.9 |
4–6.9 years (n) | 20 |
7–11.9 years (n) | 112 |
12–15.9 (n) | 113 |
Disease durations (years, mean ± SD) | 5.44 ± 3.3 |
Treatment | |
Insulin pump (n, %) | 155 (63%) |
Omnipod | 54 (35%) |
Minimed 640G | 26 (17%) |
Minimed 670G | 42 (27%) |
Paradigm | 31 (20%) |
Accuchek combo | 2 (1%) |
MDI (n, %) | 80 (33%) |
Unknown (n, %) | 10 (4%) |
Glucosensor | |
Freestyle libre | 113 (46%) |
Guardian | 58 (24%) |
Dexcom G6 | 36 (14.5%) |
Unknown | 38 (15.5%) |
Prelockdown HbA1c (mmol/mol, mean ± SD) | 58,9 ± 11.8 (n = 239) |
TIR data available (n) | 209 |
Mean sensor glucose available (n) | 214 |